The Early Cancer Institute seminar series aims to connect researchers in the early cancer detection and diagnosis space to share knowledge and spark collaboration. Join fellow researchers for lunch and an opportunity to network prior to the talk.
Click here to register
In February our speaker is Dr Jeremy Clark from UEA. Jeremy will speak on: The PUR (Prostate Urine Risk) biomarker for prostate cancer detection and prognosis.
PLEASE NOTE THIS TALK IS IN THE THEO CHALMERS LECTURE THEATRE, GROUND FLOOR, SCHOOL OF CLINICAL MEDICINE.
Speaker biography
Jeremy’s research centres around the development and clinical implementation of diagnostic and prognostic tests for Prostate Cancer.
Prostate cancer is present in the majority of men over 55 years old but only a minority of men will die of the disease. Accurate identification of those cancers that will progress and kill the patient is not available at present.
Jeremy’s research examines urine as a source of cancer biomarkers. The idea behind this is as follows: the prostate lies just below the bladder, it is a secretory organ and these secretions carry cells and molecules from all over the prostate to the urethra which then get flushed out of the body on urination. If a cancer is present, then tiny bits of the tumour are also carried with the secretions and these can be detected in urine.
In the pilot study PUR (Prostate Urine Risk Signatures), the team were able to separate men with low-risk cancer into two groups - one of which had 8-times the rate of future development of aggressive cancer than the other. This has led to the development of the At-Home Urine Collection kit whereby a urine can be collected from men At-Home for Prostate cancer testing in the laboratory.
Register for the event here: https://EarlyCancerSeminar_JeremyClark.eventbrite.co.uk
e.co.uk/e/early-cancer-institute-seminar-dr-jeremy-clark-tickets-522511444797
Date: 28th February 2023